456 related articles for article (PubMed ID: 24998824)
1. [Amyloid light chain amyloidosis].
Suzuki K; Shimizu T
Brain Nerve; 2014 Jul; 66(7):795-809. PubMed ID: 24998824
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2014 Dec; 89(12):1132-40. PubMed ID: 25407896
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin light chain amyloidosis: 2013 update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2013 May; 88(5):416-25. PubMed ID: 23605846
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin light chain amyloidosis: 2011 update on diagnosis, risk-stratification, and management.
Gertz MA
Am J Hematol; 2011 Feb; 86(2):180-6. PubMed ID: 21264900
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin light chain amyloidosis: 2016 update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2016 Sep; 91(9):947-56. PubMed ID: 27527836
[TBL] [Abstract][Full Text] [Related]
6. Current and emerging views and treatments of systemic immunoglobulin light-chain (Al) amyloidosis.
Comenzo RL
Contrib Nephrol; 2007; 153():195-210. PubMed ID: 17075231
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2018 Sep; 93(9):1169-1180. PubMed ID: 30040145
[TBL] [Abstract][Full Text] [Related]
8. Systemic immunoglobulin light-chain amyloidosis.
Comenzo RL
Clin Lymphoma Myeloma; 2006 Nov; 7(3):182-5. PubMed ID: 17229332
[TBL] [Abstract][Full Text] [Related]
9. [Light chain amyloidosis--clinical symptoms, update diagnosis, and treatment].
Charliński G; Jurczyszyn A; Wiktor-Jedrzejczak W
Przegl Lek; 2014; 71(2):102-9. PubMed ID: 25016786
[TBL] [Abstract][Full Text] [Related]
10. Progressive renal light chain amyloidosis with the absence of detectable free monoclonal light chains after an autologous hematopoietic stem cell transplant for amyloid light chain amyloidosis.
Roth RM; Benson D; Hebert LA; Bissell MG; Satoskar AA; Nadasdy T; Brodsky SV
Arch Pathol Lab Med; 2013 Sep; 137(9):1304-8. PubMed ID: 23991744
[TBL] [Abstract][Full Text] [Related]
11. Primary systemic amyloidosis.
Comenzo RL
Curr Treat Options Oncol; 2000 Apr; 1(1):83-9. PubMed ID: 12057064
[TBL] [Abstract][Full Text] [Related]
12. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].
Arbustini E; Gavazzi A; Merlini G
Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in the management of AL Amyloidosis.
Kastritis E; Dimopoulos MA
Br J Haematol; 2016 Jan; 172(2):170-86. PubMed ID: 26491974
[TBL] [Abstract][Full Text] [Related]
14. Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone +/- thalidomide for systemic light-chain amyloidosis: results of a phase II trial.
Cohen AD; Zhou P; Chou J; Teruya-Feldstein J; Reich L; Hassoun H; Levine B; Filippa DA; Riedel E; Kewalramani T; Stubblefield MD; Fleisher M; Nimer S; Comenzo RL
Br J Haematol; 2007 Oct; 139(2):224-33. PubMed ID: 17897298
[TBL] [Abstract][Full Text] [Related]
15. Light chain (AL) amyloidosis: update on diagnosis and management.
Rosenzweig M; Landau H
J Hematol Oncol; 2011 Nov; 4():47. PubMed ID: 22100031
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2024 Feb; 99(2):309-324. PubMed ID: 38095141
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin light chain amyloidosis: 2022 update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2022 Jun; 97(6):818-829. PubMed ID: 35429180
[TBL] [Abstract][Full Text] [Related]
18. New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes.
Palladini G; Dispenzieri A; Gertz MA; Kumar S; Wechalekar A; Hawkins PN; Schönland S; Hegenbart U; Comenzo R; Kastritis E; Dimopoulos MA; Jaccard A; Klersy C; Merlini G
J Clin Oncol; 2012 Dec; 30(36):4541-9. PubMed ID: 23091105
[TBL] [Abstract][Full Text] [Related]
19. [Advances in diagnosis and treatment of AL amyloidosis].
Zelichowski G; Lubas A; Wańkowicz Z
Pol Merkur Lekarski; 2008 Apr; 24(142):340-5. PubMed ID: 18634370
[TBL] [Abstract][Full Text] [Related]
20. High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study.
Perz JB; Schonland SO; Hundemer M; Kristen AV; Dengler TJ; Zeier M; Linke RP; Ho AD; Goldschmidt H
Br J Haematol; 2004 Dec; 127(5):543-51. PubMed ID: 15566357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
